Breast cancer proliferation and deterioration-associated metabolic heterogeneity changes induced by exposure of bisphenol S, a widespread replacement of bisphenol A

Biochemistry, Genetics and Molecular Biology

• Lipid 100%
• Proteomics 50%
• Molecular Biology 50%
• Mass Spectrometry 50%
• Cell Proliferation 50%
• Metabolic Pathway 50%
• DNA Methylation 50%
• Bisphenol Analogs 50%
• Lipidomics 50%
• Carcinogenesis 50%
• Protein Function 50%
• Body Weight 50%
• Ceramide 50%
• Chromosome Instability 50%
• Sphingomyelin 50%
• Dose Response 50%
• Nucleic Acid Structure 50%

Keyphrases

• Bisphenol A 100%
• Breast Cancer 100%
• Cancer Proliferation 100%
• Metabolic Heterogeneity 100%
• Breast Tumor 44%
• Spatial Distribution 22%
• Lipids 22%
• Dysregulation 11%
• Proteomics 11%
• Mass Spectrometry 11%
• Molecular Biology 11%
• Cell Proliferation 11%
• DNA Methylation (DNAm) 11%
• Sphingomyelin 11%
• Bisphenol Analogues 11%
• Necrotic Lesion 11%
• Molecular Mass 11%
• Tumor Heterogeneity 11%
• Metastasis 11%
• Lipidomics 11%
• Tumorigenesis 11%
• Protein Function 11%
• Protein-DNA Complex 11%
• Ceramide 11%
• Increased Incidence 11%
• Signaling Pathway Proteins 11%
• Nucleic Acid Structure 11%
• Metabolism Function 11%
• Chromosomal Stability 11%
• Hypoxic Tumor Microenvironment 11%
• S100 11%
• Accelerated Deterioration 11%
• Non-monotonic Dose Response 11%

Pharmacology, Toxicology and Pharmaceutical Science

• 4,4' Isopropylidenediphenol 100%
• Deterioration 100%
• Breast Cancer 100%
• Breast Tumor 100%
• Tumor Microenvironment 25%
• Sphingomyelin 25%
• Ceramide 25%
• Carcinogenesis 25%
• Nucleic Acid 25%
• Chromosomal Instability 25%